Search results for " costs"

showing 10 items of 259 documents

Health outcomes and costs in patients with osteoarthritis and chronic pain treated with opioids in Spain: the OPIOIDS real-world study.

2020

Objective: The objective of this study was to analyze health outcomes, resource utilization, and costs in osteoarthritis patients with chronic nociceptive pain who began treatment with an opioid in real-world practice in Spain. Methods: We designed a non-interventional, retrospective, longitudinal study with 36 months of follow-up using electronic medical records (EMRs) from primary care centers, of patients aged 18+ years who began a new treatment with an opioid drug in usual practice for chronic pain due to osteoarthritis. Health/non-health resource utilization and costs, treatment adherence, pain change, cognitive functioning, and dependence for basic activities of daily living (BADL) we…

medicine.medical_specialtyDiseases of the musculoskeletal systemOsteoarthritisHealth outcomescognitive deficit03 medical and health sciences0302 clinical medicineRheumatologymedicineOrthopedics and Sports MedicineIn patientpain030212 general & internal medicineCognitive deficitOriginal Research030203 arthritis & rheumatologybusiness.industrybasic activities of daily livingChronic painopioidshealthmedicine.diseasenon-health costshealth/non-health costsosteoarthritisNociceptionRC925-935OpioidPhysical therapymedicine.symptombusinessResource utilizationmedicine.drugTherapeutic advances in musculoskeletal disease
researchProduct

Epidemiology and social costs of hip fracture.

2018

Hip fracture is an important and debilitating condition in older people, particularly in women. The epidemiological data varies between countries, but it is globally estimated that hip fractures will affect around 18% of women and 6% of men. Although the age-standardised incidence is gradually falling in many countries, this is far outweighed by the ageing of the population. Thus, the global number of hip fractures is expected to increase from 1.26 million in 1990 to 4.5 million by the year 2050. The direct costs associated with this condition are enormous since it requires a long period of hospitalisation and subsequent rehabilitation. Furthermore, hip fracture is associated with the devel…

medicine.medical_specialtyFinancing PersonalPopulationDisease03 medical and health sciencesIndirect costs0302 clinical medicineAge DistributionEpidemiologyMedicineHumans030212 general & internal medicineHospital CostseducationDepression (differential diagnoses)General Environmental Science030222 orthopedicseducation.field_of_studyHip fracturebusiness.industryHip FracturesIncidence (epidemiology)IncidenceLength of Staymedicine.diseaseHospitalizationSarcopeniaQuality of LifeGeneral Earth and Planetary SciencesbusinessHip fracture Social cost EpidemiologyDemographyInjury
researchProduct

Klinische und ökonomische Evaluation der Inanspruchnahme zahnärztlicher Leistungen im Ausland

2003

Purpose During the past decade German patients developed an increasing tendency to dental health tourism in countries outside the European Union. The present investigation aimed at evaluating both clinical and economic outcome of dental care in these countries with regard to German directive standards. Methods Based on physical examinations performed by the Medizinische Dienst der Krankenversicherung Rheinland-Pfalz in the context of reimbursement or regress requests after dental care in countries outside the European Union, an individual treatment concept was designed and its direct costs from the patient's perspective were estimated according to German standards. Furthermore, the clinical…

medicine.medical_specialtyHealth economicsbusiness.industryPublic Health Environmental and Occupational HealthMEDLINEContext (language use)Directivelanguage.human_languageGermanIndirect costsNursingFamily medicinelanguagemedicinemedia_common.cataloged_instanceEuropean unionbusinesshealth care economics and organizationsReimbursementmedia_commonDas Gesundheitswesen
researchProduct

Treatment cost of invasive fungal disease (Ifd) in patients with acute myelogenous leukaemia (Aml) or myelodysplastic syndrome (Mds) in German hospit…

2012

Invasive fungal disease (IFD) causes increasing morbidity and mortality in haematological cancer patients. Reliable cost data for treating IFD in German hospitals is not available. Objective of the study was to determine the institutional cost of treating the IFD. Data were obtained by retrospective chart review in German hospitals. Patients had either newly diagnosed or relapsed acute myeloid leukaemia (AML) or myelodysplastic syndrome (MDS). Direct medical cost was calculated from hospital provider's perspective. A total of 108 patients were enrolled at 5 tertiary care hospitals, 36 IFD patients and 72 controls. The vast majority of IFD patients (74%) were diagnosed with invasive aspergil…

medicine.medical_specialtyMyeloidbusiness.industryMyelodysplastic syndromesRetrospective cohort studyDermatologyGeneral MedicineAspergillosismedicine.diseaseIndirect costsInfectious DiseasesInvasive fungal diseasePharmacotherapymedicine.anatomical_structureInternal medicinemedicineYoung adultbusinessIntensive care medicineMycoses
researchProduct

Work-related burnout syndrome in physicians in Spain

2020

Abstract This article brings together the views of a working group to deliberate on burnout among physicians in Spain. The document is the result of the answers that different members of the group have prepared to different questions on the subject with conclusions derived from the discussion among all the participants. Burnout is an entity with a high incidence in physicians, with serious work, personal and economic repercussions, whose recognition as a disease is changing in recent years. Particularly affected are some specialties, such as Primary Care, Oncology, Intensive Care Medicine, and Palliative Care. The common factor being an increased qualitative or quantitative demand on the pr…

medicine.medical_specialtyPalliative carebusiness.industryIncidence (epidemiology)General MedicineDiseaseBurnoutWork related03 medical and health sciencesIndirect costs0302 clinical medicineWork (electrical)Family medicineAbsenteeismMedicine030212 general & internal medicinebusinessRevista Clínica Española (English Edition)
researchProduct

The Burden of Pediatric Asthma

2018

Asthma is the most common chronic disease in children, imposing a consistent burden on health system. In recent years, prevalence of asthma symptoms became globally increased in children and adolescents, particularly in Low-Middle Income Countries (LMICs). Host (genetics, atopy) and environmental factors (microbial exposure, exposure to passive smoking and air pollution), seemed to contribute to this trend. The increased prevalence observed in metropolitan areas with respect to rural ones and, overall, in industrialized countries, highlighted the role of air pollution in asthma inception. Asthma accounts for 1.1% of the overall global estimate of "Disability-adjusted life years" (DALYs)/100…

medicine.medical_specialtyPassive smokingTotal costMini ReviewprevalencemorbidityDiseasemedicine.disease_causePediatricsburden03 medical and health sciencesIndirect costs0302 clinical medicineQuality of life (healthcare)childrenEnvironmental healthEpidemiologycostMedicine030212 general & internal medicineAsthmabusiness.industrylcsh:RJ1-570lcsh:Pediatricsasthmamedicine.diseasemortality030228 respiratory systemPediatrics Perinatology and Child HealthepidemiologybusinessDeveloped countryFrontiers in Pediatrics
researchProduct

Prevention of eating disorders-Efficacy and cost-benefit of a school-based program ("MaiStep") in a randomized controlled trial (RCT).

2021

Objective Given the severity of eating disorders, effective and easily implementable prevention programs which reduce incidence rates and in addition have health-economic benefits are essential. The majority of research on prevention programs focuses on questionnaire-based efficacy or the reduction of eating disorder symptoms while neglecting the health-economic perspective. By contrast, the present study focuses on both an efficacy analysis considering diagnostic criteria (DSM-5) and on evaluating the cost-benefit of a universal prevention program for eating disorders ("MaiStep"). Method A three-arm randomized controlled trial with baseline, posttreatment and 12-month follow-up was conduct…

medicine.medical_specialtySchoolsAdolescentbusiness.industryBulimia nervosaCost-Benefit AnalysisHealth Care Costsmedicine.diseaseDSM-5law.inventionClinical trialFeeding and Eating DisordersPsychiatry and Mental healthEating disordersRandomized controlled triallawIntervention (counseling)Relative riskHealth carePhysical therapyMedicineHumansbusinessStudentsThe International journal of eating disordersREFERENCES
researchProduct

Adherence, compliance and persistence to oral antineoplastic therapy: a review focused on chemotherapeutic and biologic agents

2011

Introduction: To date, orally administered chemotherapy and biologic agents represent a significant percentage of all antineoplastic treatments in several types of cancer, which are most likely to increase in the near future. In this scenario, the issue of adherence and persistence to oral therapy is a key issue since poor compliance to oral antineoplastic treatments may negatively influence patients' clinical outcomes and, in turn, cause an increase in costs, number of hospitalizations and time spent in the hospital. Areas covered: The issue of adherence to new oral chemotherapeutic and/or biologic agents has not been deeply evaluated and data published in medical literature are quite scar…

medicine.medical_specialtySettore MED/06 - Oncologia MedicaPoor compliancemedicine.medical_treatmentAdministration OralAntineoplastic AgentsPharmacologySocioeconomic FactorMedication AdherencePersistence (computer science)PersistenceAntineoplastic AgentImmunologic FactorNeoplasmsHumansImmunologic FactorsMedicinePharmacology (medical)Intensive care medicineOral therapyCancerChemotherapybusiness.industryCancerHealth Care CostsGeneral MedicineDrug adherencemedicine.diseaseBiologic AgentsHealth Care CostHospitalizationSocioeconomic FactorsAdherenceNeoplasmbusinessOral chemotherapyHumanMedical literatureExpert Opinion on Drug Safety
researchProduct

Are we really seeing the total costs of surgical site infections? A Spanish study.

2007

To identify overall costs generated by surgical site infections (SSI) patients, including indirect costs. A prospective study of case series of patients who have undergone major surgical treatment was undertaken. Patients who suffered SSI were compared with controls (nested case-control design). Centers for Disease Control and Prevention definitions were followed and SSI established. Overall costs and indirect related morbidity/mortality costs were estimated. The study was performed in a general, tertiary hospital (Valencia, Spain) for 4.5 years. Surgical site infections patients were 9.02% of the total people who underwent surgery. Their stays were prolonging by 14 days, and resources were…

medicine.medical_specialtyTotal costbusiness.industryDermatologyLength of Staymedicine.diseaseDisease controlIndirect costsCost of IllnessSpainEmergency medicineHealth careSurgical siteCost of illnessmedicineHumansSurgical Wound InfectionSurgeryMedical emergencyHospital CostsbusinessSurgical treatmentProspective cohort studyhealth care economics and organizationsWound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society
researchProduct

Out-of-pocket costs in gastrointestinal cancer patients: Lack of a perfectly framed problem contributing to financial toxicity

2021

Abstract Fighting cancer is an economically expensive challenge for both health care payers, and the patients and their families and the median costs for cancer care are rapidly increasing in the last decade. Although both direct and indirect costs of medical assistance have been a frequent source of distress and contention, however analysis of the non-medical expenses incurred directly by cancer patients has not received adequate attention. Developing a deeper understanding of so-called "out-of-pocket" costs may be necessary. Out-of-pocket costs for medical care range from 7 % to 11 % of medical costs for all payers. However, the range of out-of-pocket costs shows considerable variability …

medicine.medical_specialtybusiness.industryCancerHematologymedicine.diseaseMedical careDistressIndirect costsCost of IllnessOncologyHealth caremedicineHumansPatient CareGastrointestinal cancerHealth ExpendituresbusinessIntensive care medicineMedical costsPsychosocialhealth care economics and organizationsGastrointestinal NeoplasmsCritical Reviews in Oncology/Hematology
researchProduct